Hepatocellular Carcinoma Clinical Trials in Shanghai, Shanghai Municipality
25 recruitingShanghai, Shanghai Municipality, China
Showing 1–20 of 25 trials
Recruiting
Phase 2
HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)
Hepatocellular Carcinoma (HCC)
Fudan University164 enrolled1 locationNCT06860490
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Hepatocellular Carcinoma (HCC)
Bristol-Myers Squibb129 enrolled46 locationsNCT07291076
Recruiting
Phase 2
Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)
Hepatocellular Carcinoma (HCC)
Ruijin Hospital35 enrolled4 locationsNCT07331883
Recruiting
Phase 1Phase 2
A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma
Shanghai AbelZeta Ltd.121 enrolled2 locationsNCT06590246
Recruiting
Phase 2
ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
Hepatocellular Carcinoma (HCC)
Abbisko Therapeutics Co, Ltd141 enrolled51 locationsNCT07327034
Recruiting
Phase 2Phase 3
The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD
HCC - Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital20 enrolled1 locationNCT07285850
Recruiting
Phase 2
Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab
Hepatocellular Carcinoma (HCC)
Fudan University141 enrolled1 locationNCT07100392
Recruiting
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment
Hepatocellular Carcinoma
Fudan University50 enrolled1 locationNCT07100405
Recruiting
Phase 2
JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd.72 enrolled12 locationsNCT06954467
Recruiting
Phase 2
Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab
Hepatocellular Carcinoma (HCC)
Fudan University146 enrolled1 locationNCT07047586
Recruiting
Phase 1Phase 2
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Gastric CancerHepatocellular CarcinomaNon-small Cell Lung Cancer+3 more
Shanghai Public Health Clinical Center40 enrolled1 locationNCT03093688
Recruiting
Early Phase 1
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
Advanced Hepatocellular Carcinoma
Shanghai Changzheng Hospital37 enrolled1 locationNCT06418659
Recruiting
Phase 3
A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection
Hepatocellular Carcinoma
Akeso570 enrolled1 locationNCT05489289
Recruiting
Phase 2
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
RadiotherapyHCC - Hepatocellular Carcinoma
Shanghai Zhongshan Hospital35 enrolled1 locationNCT06870942
Recruiting
Phase 1
A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma (HCC)
AbbVie20 enrolled11 locationsNCT06487559
Recruiting
Phase 2
Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
Fudan University25 enrolled1 locationNCT05057845
Recruiting
The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
Hepatocellular Carcinoma (HCC)
Ruijin Hospital40 enrolled1 locationNCT06746194
Recruiting
Early Phase 1
Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine12 enrolled1 locationNCT06652243
Recruiting
Phase 1
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
Hepatocellular CarcinomaHCCHepatitis B Virus Related Hepatocellular Carcinoma
SCG Cell Therapy Pte. Ltd.38 enrolled7 locationsNCT06617000
Recruiting
Phase 3
Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.480 enrolled67 locationsNCT05862337